Erbitux Alternatives Compared
| Erbitux | Yervoy | Oxaliplatin |
|
|---|
| Erbitux (cetuximab) | Yervoy (ipilimumab) | Oxaliplatin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Colorectal Cancer, Squamous Cell Carcinoma, Head and Neck Cancer. Erbitux may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Melanoma - Metastatic, Colorectal Cancer, Melanoma, Malignant Pleural Mesothelioma, Renal Cell Carcinoma. Yervoy may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Colorectal Cancer. oxaliplatin may also be used for purposes not listed in this medication guide. |
Related suggestions Colorectal Cancer
|
|||||||||||||||||||||||
| More about Erbitux (cetuximab) | More about Yervoy (ipilimumab) | More about Oxaliplatin | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Erbitux has an average rating of 6.9 out of 10 from a total of 8 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 13% reported a negative effect. |
Be the first to share your experience with this drug. |
Oxaliplatin has an average rating of 4.0 out of 10 from a total of 4 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 60% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Erbitux side effects in more detail. |
See also: Yervoy side effects in more detail. |
Commonly reported side effects include:
See also: oxaliplatin side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Erbitux prices |
View all Yervoy prices |
View all oxaliplatin prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Eloxatin | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
213 hours |
352.8 hours |
391 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 20 drugs are known to interact with Erbitux:
|
A total of 140 drugs are known to interact with Yervoy:
|
A total of 564 drugs are known to interact with oxaliplatin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
February 12, 2004 |
March 25, 2011 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.